Serum vasoactive agents in lead-treated rats

International Journal of Occupational Medicine and Environmental Health

Volumn 16, Issue 2, 2003, Pages 169-177

  Skoczyńska, Anna ^a   Stojek, Ewa ^a   Górecka, Helena ^b   Wojakowska, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Endothelin; Lead; Lipid peroxidation; Nitric oxide; Rats

Indexed keywords

COPPER; DRINKING WATER; ENDOTHELIN 1; GLUTATHIONE; KETAMINE; LEAD; LIPID PEROXIDE; NITRIC OXIDE; PROSTAGLANDIN F2 ALPHA; SUCROSE; VASOACTIVE AGENT; ZINC;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL WALL; BODY WEIGHT; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HEART; HOMEOSTASIS; HYPERTENSION; KIDNEY; LONG TERM EXPOSURE; MALE; MEASUREMENT; NONHUMAN; OXIDATION REDUCTION REACTION; RAT; SPECTROMETRY; THORACIC AORTA;

EID: 18544409337     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Khalil-Manesh F, Gonick HC, Weiler EW, Prins B, Weber MA, Purdy ME. Lead-induced hypertension: possible role of endothelial factors. Am J Hypertens 1993; 6: 723-9.
2. Tsao D, Yu HS, Cheng JT, Ho CK, Chang HR. The change of beta-adrenergic system in lead-induced hypertension. Toxicol Appl Pharmacol 2000 164; 2:127-33.
3. Skoczyńska A, Juzwa W, Smolik R, Szechiński J, Behal FJ. Response of the cardiovascular system to catecholamines in rats given small doses of lead. Toxicology 1986; 39: 275-89.
4. Victery W. Evidence for effects of chronic lead exposure on blood pressure in experimental animals: an overview. Environ Health Perspect 1988; 78: 71-6.
5. Boscolo P, Carmignani M. Neurohumoral blood pressure regulation in lead exposure. Environ Health Perspect 1988; 78: 101-6.
6. Victery W, Wander A, Shulak JM, Schoeps P, Julius S. Lead, hypertension and the renin-angiotensin system in rats. J Lab Clin Med 1982; 99: 354-62.
7. Chang HR, Chen SS, Tsao DA, Cheng JT, Ho CK, Yu HS. Reduced vascular beta-adrenergic receptors and catecholamine response in rats with lead induced hypertension. Arch Toxicol 1997; 71: 778-81.
8. Watts SW, Chai S, Webb RC. Lead acetate-induced contraction in rabbit mesenteric artery: interaction with calcium and protein kinase C. Toxicology 1995; 99: 55-65.
9. Gurer H, Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Rad Biol Med 2000; 29(10): 927-45.
10. Marques M, Millas I, Jimenez A, Garcia-Colis E, Rodriguez-Feo JA, Velasco S, et al. Alteration of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertension in rats. J Am Soc Nephrol 2001; 12: 2594-600.
11. Schwartz J. Lead, blood pressure, and cardiovascular diseases in men and woman. Environ Health Perspect 1991; 91: 71-5.
12. Nakhoul F, Kayne LH, Brautbar N. Raid hypertensiogenic effect of lead. Studies of the spontaneously hypertensive rat. Toxicol Ind Health 1992; 8:89-92.
13. Staessen J, Yeoman WB, Flechter AE, Markowe HL, Marmot MG, Rose G, et al. Blood lead concentration, renal function and blood pressure in London civil servants. Br J Ind Med 1990; 47: 442-7.
14. Maheswaran R, Gill JS, Beevers DG. Blood pressure and industrial lead exposure. Am J Epid 1993; 137: 645-53.
15. Vaziri ND, Ding Y, Ni Z, Gonick HC. Altered nitric oxide metabolism and increased oxygen free radicals activity in lead-induced hypertension: effect of lazaroid therapy. Kidney Int 1997; 52: 1042-6.
16. Vaziri ND, Ding Y, Ni Z. Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension 1999; 34: 558-62.
17. Ding Y, Vaziri ND, Gonick HC. Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ Res 1998; 76: 107-13.
18. Gonick HC, Ding Y, Bondy SC, Ni Z, Vaziri ND. Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension 1997; 30: 1487-92.
19. Skoczyńska A, Wróbel J, Andrzejak R. Impaired endothelial-mediated vascular function in vessels of rats poisoned with lead and cadmium. Metal Ions Biol Med. 2000; 6: 646-8.
20. Stojek E, Skoczyńska A. Endothelial dysfunction in mesenteric bed of rats poisoned with lead. Abstracts of 22nd Meeting of the European Society for Microcirculation, Exeter, Devon, UK, August 28-30, 2002. J Vas Res 2002; 39(S1): 24.
21. Vaziri ND, Liang K, Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 1999; 56: 1492-8.
22. Khalil-Manesh F, Gonick HC, Weiler EWJ, Prins B, Weber MA, Purdy R, et al. Effects of chelation treatment with DMSA on lead-related blood pressure changes. Environ Res 1994; 65: 86-99.
23. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978; 90: 37-43.
24. Malvezzi CK, Moreira EG, Vassilieff I, Vassilieff VS, Cordellini S. Effect of L-arginine, DMSA and the association of L-arginine and DMSA on tissue lead mobilization and blood pressure level in plumbism. Braz J Med Biol Res 2001; 34: 1341-6.
25. Miniuk K, Moniuszko-Jakoniuk J, Kulikowska E, Omeljaniuk N. The interactions of copper, lead and ethanol in rats: effects on some biochemical parameters of blood. Pol J Pharm 1989; 41: 273-80.
26. Purdy RE, Smith JR, Ding Y. Lead-induced hypertension is not associated with altered vascular reactivity in vitro. Am J Hyperten 1997; 10: 997-1003.
27. Carmignani M, Volpe AR, Boscolo P, Qiao N, Gioacchino MD, Grilli A, et al. Catecholamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment. Life Sci 2000; 68: 401-15.
28. Kort WL, Verschoor MA, Wibowo AA, Van Hemmen JJ. Occupational exposure to lead and blood pressure. A study in 105 workers. Am J Ind Med 1987; 11: 145-56.
29. Harlan WR. The relationship of blood lead levels to blood pressure in the U.S. population. Environ Health Perspect 1988; 78: 9-13.
30. Vaziri ND, Ding Y. Effect of lead on nitric oxide synthase expression in coronary endothelial cells - role of superoxide. Hypertension 2001; 37: 223-6.
31. Krocova Z, Macele A, Kroca M, Hemychova L. The immunomodulatory effects of lead and cadmium on the cells of immune system in vitro. Toxicol Vitro 2000; 14: 33-44.
32. Ergul A. Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents. Pharmacotherapy 2002; 22: 54-56.
33. 2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem 1994; 269: 11938-44.
34. Hocher B, Thone-Reineke C, Bauer C. The paracrine endothelin system: pathophysiology and implications in clinical medicine. Eur J Clin Chem Clin Biochem 1997; 35: 175-89.
35. Daggett DA, Oberley TD, Nelson SA, Wright LS, Komguth SE, Siegel FL. Effects of lead on rat kidney and liver GST expression and oxidative stress. Toxicology 1998; 128: 191-206.
36. Kachur AV, Koch CJ, Biaglow JE: Mechanism of copper-catalysed autooxidation of cysteine. Free Radic Res 1999; 31: 23-34.
37. Kachur AV, Koch CJ, Biaglow JE: Mechanism of copper-catalysed oxidation of glutathione. Free Radic Res 1998; 28: 259-69.